Where does Behzad Aghazadeh work?

Behzad Aghazadeh is Managing Partner & Portfolio Manager at Avoro Capital Advisors and Board director at Scribe Therapeutics.

Behzad Aghazadeh

Investor

Managing Partner & Portfolio Manager at Avoro Capital Advisors · Board director at Scribe Therapeutics

About

Managing Partner and Portfolio Manager of Avoro Capital with over 25 years in the biopharmaceutical industry across research, consulting, investing and board leadership. He holds a physics master's from Ludwig-Maximilians-University and a PhD in Biochemistry & Biophysics from Cornell, and served as Executive Chairman of Immunomedics until its $21B acquisition by Gilead in 2020.

Contact· self-published, not guessed

b•••@avorocapital.comreveal

Board director at Scribe Therapeutics

Intro paths

→

In turn, Behzad can intro founders to Scribe Therapeutics's investors below.

Scribe Therapeutics's investors · 6

Andreessen HorowitzMenlo Park · $500K – $50M checks · since 2021 Avoro Capital AdvisorsNew York · since 2021 Avoro VenturesNew York · since 2021 Menlo VenturesSan Francisco · $1M – $20M checks · since 2021 OrbiMedNew York · $1M – $75M checks · since 2021 RA CapitalBoston · since 2021

Co-founders at Scribe Therapeutics

Benjamin OakesFounder & CEO

Jennifer A. Doudna, PhDCo-founder, Scientific Advisor

Benjamin L. Oakes, PhDCo-founder, President and CEO

David F. Savage, PhDCo-founder, Scientific Advisor

Brett Staahl, PhDCo-founder, VP of External Innovation

Colleagues at Avoro Capital Advisors

Andy Washkowitz

Director at Avoro Capital Advisors

Billy Smith

Associate at Avoro Capital Advisors

Bryan Phillips

Deputy Chief Compliance Officer at Avoro Capital Advisors

Corie Hansen

Office Manager / Executive Assistant at Avoro Capital Advisors

David Xiang

Associate at Avoro Capital Advisors

Diane Chien

Hedge Fund Controller at Avoro Capital Advisors

Jenna Glatzer

Associate - Avoro Ventures at Avoro Capital Advisors

Jenna McElhinney

Manager, Investor Relations & Marketing at Avoro Capital Advisors

Frequently asked questions

Who is Behzad Aghazadeh?: Managing Partner and Portfolio Manager of Avoro Capital with over 25 years in the biopharmaceutical industry across research, consulting, investing and board leadership. He holds a physics master's from Ludwig-Maximilians-University and a PhD in Biochemistry & Biophysics from Cornell, and served as Executive Chairman of Immunomedics until its $21B acquisition by Gilead in 2020.
Where does Behzad Aghazadeh work?: Behzad Aghazadeh is Managing Partner & Portfolio Manager at Avoro Capital Advisors and Board director at Scribe Therapeutics.